Biorasis, Inc., a UConn-based startup located on the Storrs campus, is pioneering the development of miniaturized implantable metabolic sensors aimed at advancing real-time health monitoring. The company’s current focus is on creating a next-generation Continuous Glucose Monitor (CGM), called the Glucowizzard, for patients with Type I and Type II diabetes. As part of the system, Biorasis, Inc. requires the development of a robust, smartphone-based Medical Mobile App (MMA) to interface with its implantable CGM device via a Proximity Communicator. The objective of the project was to design and develop an intuitive and reliable mobile application that communicates with the Glucowizzard via Bluetooth Low Energy (BLE), using the Proximity Communicator. Our app enables seamless and secure data exchange between the implanted sensor and the user's mobile device, providing real-time glucose readings, data visualization, and data storage for long-term monitoring. Key milestones of our project included: researching current CGM mobile solutions, designing an accessible and functional graphical user interface (GUI), implementing high-integrity data handling, and successfully integrating the app with Biorasis’ Proximity Communicator. This mobile application will play a critical role in supporting Biorasis’ mission to improve diabetes management through innovative sensor technology and user-centered digital tools.